Results 121 to 130 of about 978,532 (309)
Financial Knowledge and Private Health Insurance: Does Age Matter? [PDF]
Aguiar-Díaz I, Ruiz-Mallorquí MV.
europepmc +1 more source
Coverage generosity of novel anti‐rheumatic drugs in Medicare Advantage and stand‐alone Part D plans
Objective To examine coverage of self‐administered disease‐modifying anti‐rheumatic drugs (DMARDs) in Medicare Part D. Methods Using 2022‐2026 Part D formulary data, we assessed coverage of the following DMARD classes that treat relapsed rheumatoid arthritis (RA): tumor necrosis factor (TNF) inhibitors, T‐cell co‐stimulatory modulator, Interleukin‐6 ...
Youngmin Kwon +2 more
wiley +1 more source
ANK1 and EPB41 Variants and The Risk of Steroid‐Induced Osteonecrosis
Objective Steroid‐induced osteonecrosis of the femoral head (SONFH) is a refractory skeletal disorder influenced by genetic and environmental factors. However, conclusive pathogenic genetic evidence remains elusive due to the limited exploration of rare damaging variants. In this study, we aimed to identify rare variants associated with SONFH.
Shengbao Chen +21 more
wiley +1 more source
Whither private health insurance? [PDF]
J, Hall, R, Viney, R, de Abreu Lourenco
openaire +2 more sources
Introduction OOPE for healthcare services is a major concern within the Indian healthcare system. 30% of the population remains uninsured despite increasing health insurance coverage. For obstetrics and gynaecology (OBG) patients financial obstacles like
Dr. Kumar Sumit +7 more
doaj +1 more source
The public view of private health insurance, CHERE Discussion Paper No 45 [PDF]
Until the 1996 Federal election, the Liberal Party remained committed to the repeal of Medicare. In that election the Liberal platform endorsed the continuation of Medicare, and support for private health insurance.
Jane Hall
core
Reviews updated research on the extent to which expanding public health insurance programs reduces the role of private insurance, the impact of anti-crowd-out measures, and contributing factors such as incomes, enrollment patterns, and economic ...
Kathleen T. Call, Lynn A. Blewett
core
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley +1 more source
The Development of the Irish Private Health Insurance Market and Evidence of Selection Effects Therein [PDF]
This paper tracks the development of the Irish private health insurance market, both in terms of its legislative background and the development of competition. Literature on adverse selection and risk selection is then reviewed.
Brian Turner, Edward Shinnick
core

